Amy Rabourn

Overview

Amy Rabourn received an average of $366K in total compensation, including $178K in salary, at Rexahn Pharmaceuticals from 2020 to 2022.

Source: SEC filings on May 1, 2023, April 27, 2022, and April 26, 2021.

Related executives

We found ten more executives who work or worked at Rexahn Pharmaceuticals.

Mina Sooch

Rexahn Pharmaceuticals

Chief Executive Officer

Bernhard Hoffmann

Rexahn Pharmaceuticals

Vice President of Corporate Development and Operations

Douglas Swirsky

Rexahn Pharmaceuticals

Chief Executive Officer

Peter Suzdak

Rexahn Pharmaceuticals

Chief Executive Officer

Ely Benaim

Rexahn Pharmaceuticals

Chief Medical Officer

Lisa Nolan

Rexahn Pharmaceuticals

Secretary

Tae Jeong

Rexahn Pharmaceuticals

Chief Financial Officer

Rakesh Soni

Rexahn Pharmaceuticals

Chief Operating Officer

News

You may also like